ClinVar Miner

Submissions for variant NM_000038.6(APC):c.2354A>G (p.His785Arg)

dbSNP: rs1765161032
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003652107 SCV001420273 uncertain significance Familial adenomatous polyposis 1 2022-12-24 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 971162). This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 785 of the APC protein (p.His785Arg).
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001284236 SCV001469905 uncertain significance not provided 2019-11-27 criteria provided, single submitter clinical testing
Ambry Genetics RCV003284124 SCV004005120 uncertain significance Hereditary cancer-predisposing syndrome 2023-03-30 criteria provided, single submitter clinical testing The p.H785R variant (also known as c.2354A>G), located in coding exon 15 of the APC gene, results from an A to G substitution at nucleotide position 2354. The histidine at codon 785 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.